Relief Therapeutics Holding AG (RLFTF)

[tcm55]

My opinion is that RLF is trying to set too high a price for a drug that will compete with Remedysevere's* exposure. Many will chose the semi proven/semi affective - publicized Rem. IMO. Most will never get mabs/antigens either, course price issues too.
With the low cost of manufacturing(?) Aviptadil, a serious look at pricing may be an answer to getting this drug out. Sure some logistics issues until something with the Inhaler is accomplished. Other competition may be as effective/much less expensive and all will have Trials to prove it.
No magic this late in the race, IMO. I dont think recruitment of DT or for Trials with the IV course is as accepted against current treatments or priced reasonably to get some attention.?. 3X Rem?.
Phobic DT and populace/insurance companies.?. Few want a vaccine yet, if/when.?.
Data from lackluster enrollments Q1 2021.?. Prophylactic use/Compassionate use/not easily administered IV course.?.
Very happy there is now a Site for Inhaler Trials to be registered.

Tif, excellent DD-COVID chart/map. My thanks. Seems to be lost in recent postings, repost may be in order.


*(Gilead-Rem/Wuhan China origins)Initial escape during research. batsoup??? I dont think so...